The AHA Guidelines and Scientific Statements Handbook

Index

Clot, intramural 345
Coagulation 150
Cocaine 241
Colchicine 78
Colesevelam 190
Colestipol 190
Collagen disorders 240
Collapse, hemodynamic 71–2
COMMIT Study 26
Committee on Rheumatic Fever, Endocarditis, and
Kawasaki Disease 312, 332
Compression, celiac trunk 345
Compromise, hemodynamic 58, 71, 73–4, 150, 276–7
Computed tomography angiography. See CTA
Conduction 240, 275
antegrade 258, 263
Congenital heart disease. See CHD
Congestion, pulmonary 54, 64, 70
Congestive heart failure. See HF
Continuous positive airway pressure 66
Coronary
artery noncalcifi ed plaque 336–7, 342
atherosclerotic heart disease. See CASH-D
heart disease. See CHD
Cororary artery bypass graft. See CABG
Coronary Artery Bypass Graft Patch Trial 279
Coronary artery calcifi ed plaque. See CACP
Coronary artery calcium 336–43
Corticosteroids 78, 189, 192
Councils on Clinical Cardiology and Epidemiology 196,
203, 271
Counterpulsation, intra-aortic balloon 69–70 69, 72
COURAGE Trial 132, 349–50
COX-2 34, 54, 85
Coxsackie 241
CPR 50, 276
CPVT 239–40, 287
CRD 205, 215, 217, 219–20
Creatine kinase-MB. See CK-MB
Creatinine 63, 68, 70, 202, 207
clearance 26, 42, 44, 63, 132, 317
serum 210, 225
CR/SP 91–2, 100, 104
defi ned 92
performance measurement sets 102, 104–7
Cryoablation 263
Cryoprecipitate 57
CSA 5, 9, 32, 92, 104, 208, 228, 232
CTA 25, 32–3, 37, 39–40, 44–5, 54, 172–3, 182–3, 274,
300, 302, 336–54
coronary 343
mesenteric artery 345
renal artery 344

Cultures, blood 314–5, 321, 323, 331–2

CVD 91, 154, 158, 187–9, 193–5, 197–8, 211, 214–22

Cyclooxygenase (COX)-2-selective agents. See COX-2

Cyclophosphamide 241

Cyclosporine 190

DASH diet 203, 211–2

Daunorubicin 240–1

DBP 197–200, 204–5

DCM 236–7, 240–2

nonischemic 284

Death 164, 167, 175, 214–5, 221–2, 238, 240, 242

cardiac 150, 230, 238–40, 270

275–98 291

sudden 270–92

cardiovascular 163, 236

nonarrhythmic 281

vascular 175

Defi brillation 50, 66

Defi brillator in Acute Myocardial Infarction Trial 279–80

Defi brillators 276, 289, 291–2

Defi brillators in Nonischemic Cardiomyopathy Treatment

Evaluation 279

Dehiscence

partial 313–4

valvular 316, 325

Denervation, sympathetic neural 287

Depression, emotional 29, 44, 85, 87, 101, 106, 214, 221

Depression, ST-segment 27, 39, 45, 56, 60, 126, 274

Dermatomyositis 241

DES 26, 109, 111, 117, 130, 132, 146, 151, 159, 164, 349

Desmin 241

Desmoglein 239

Desmoplakin 239

DHA 218

Diabetes mellitus. See DM

Diabetic nephropathy 227

Diagnosis 165, 171, 174, 182

etiologic 329

Dialysis 290

Diastolic blood pressure. See DBP

Diet 67, 203, 211–2, 214–5, 218, 226, 270, 283

cholesterol-lowering 189. See also Nutritional

counseling

Digitalis 230, 232, 234, 246, 252, 267, 290

Digoxin 74–5, 140, 227, 245–6, 250, 259, 261, 264–5, 274,

289

Dihydropyridine 17

Dilatation 300, 302

Dilated cardiomyopathy. See DCM

Dilation

aortic root 302

balloon 179